Nantahala Capital Management, LLC
13F Reported Value
ⓘ$3.0B
incl. option notional
Equity Holdings
ⓘ$1.6B
Option Notional
ⓘ$1.4B
$846.0M puts / $513.3M calls
Holdings
152
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Nantahala Capital Management, LLC disclosed 152 positions worth $3.0B in its Form 13F-HR for Q2 2026 — $1.6B in common stock plus $1.4B of put/call option positions (reported at underlying notional value, not premium at risk), followed by $PTON and $HLF. During the quarter the fund opened 26 new positions and exited 25 and a full exit from $SLNO. The portfolio is most concentrated in Healthcare (62.5% of disclosed assets). All figures are sourced directly from Nantahala Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1472322.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
ISHARES TR - RUSSELL 2000 ETF PUT
—Quality
$600.9M2,000,000 sh- 54.3#1,343
Quality
$97.2M16,438,900 sh - —
Quality
$86.8M6,600,000 sh - 45.4
Quality
$79.4M5,000,000 sh - 61.1
Quality
$77.7M1,239,887 sh - 69.4
Quality
$72.4M800,000 sh SPDR SERIES TRUST - ST STR SP BIOT PUT
—Quality
$63.3M400,000 sh- 59.9
Quality
$56.6M6,000,279 sh - 56.1
Quality
$56.3M1,075,000 sh - 56.1
Quality
$54.1M1,033,170 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| ISHARES TR - RUSSELL 2000 ETF PUT | — | $600.9M | 2,000,000 |
 PELOTON INTERACTIVE, INC.$PTONCALL | 54.3#1,343 | $97.2M | 16,438,900 |
 HERBALIFE LTD.$HLFCALL | — | $86.8M | 6,600,000 |
 Viatris Inc$VTRSCALL | 45.4 | $79.4M | 5,000,000 |
 Bancorp, Inc.$TBBK | 61.1 | $77.7M | 1,239,887 |
 Edwards Lifesciences Corp$EWPUT | 69.4 | $72.4M | 800,000 |
| SPDR SERIES TRUST - ST STR SP BIOT PUT | — | $63.3M | 400,000 |
 Bioventus Inc.$BVS | 59.9 | $56.6M | 6,000,279 |
 Hilton Grand Vacations Inc.$HGVCALL | 56.1 | $56.3M | 1,075,000 |
| Hilton Grand Vacations Inc.$HGV | 56.1 | $54.1M | 1,033,170 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Nantahala Capital Management, LLC's 152 positions.
Showing top 10 of 152 holdings.
Sector Allocation
Healthcare
$1.0B
Consumer Discretionary
$208.1M
Financials
$128.1M
Technology
$118.8M
Communication Services
$58.7M
Industrials
$37.7M
Materials
$21.5M
Consumer Staples
$20.8M
Full Holdings — Nantahala Capital Management, LLC (Q2 2026)
All 152 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | ISHARES TR - RUSSELL 2000 ETF | $600.9M | — | -2% | — |
| 2 | $PTONCALL | PELOTON INTERACTIVE, INC. | $97.2M | — | -8% | 54.3 |
| 3 | $HLFCALL | HERBALIFE LTD. | $86.8M | — | +18% | — |
| 4 | $VTRSCALL | Viatris Inc | $79.4M | — | +0% | 45.4 |
| 5 | $TBBK | Bancorp, Inc. | $77.7M | 4.7% | -10% | 61.1 |
| 6 | $EWPUT | Edwards Lifesciences Corp | $72.4M | — | +0% | 69.4 |
| 7 | — | SPDR SERIES TRUST - ST STR SP BIOT | $63.3M | — | +33% | — |
| 8 | $BVS | Bioventus Inc. | $56.6M | 3.4% | -2% | 59.9 |
| 9 | $HGVCALL | Hilton Grand Vacations Inc. | $56.3M | — | +0% | 56.1 |
| 10 | $HGV | Hilton Grand Vacations Inc. | $54.1M | 3.3% | -32% | 56.1 |
| 11 |  $SVRA | Savara Inc | $43.0M | 2.6% | -5% | — |
| 12 |  $ETON | Eton Pharmaceuticals, Inc. | $42.6M | 2.6% | +0% | 67.5 |
| 13 |  $AMRX | Amneal Pharmaceuticals, Inc. | $39.3M | 2.4% | -20% | 58.5 |
| 14 |  $EOLS | Evolus, Inc. | $38.9M | 2.4% | -12% | 39 |
| 15 | — | ETF SER SOLUTIONS - DEFIA QUANT ETF | $36.9M | — | NEW | — |
| 16 |  $QURECALL | uniQure N.V. | $36.8M | — | -69% | — |
| 17 |  $AVTX | Avalo Therapeutics, Inc. | $34.4M | 2.1% | +51% | 11.7 |
| 18 |  $LBRX | LB PHARMACEUTICALS INC | $34.2M | 2.1% | +0% | — |
| 19 |  $NBIXCALL | NEUROCRINE BIOSCIENCES INC | $33.7M | — | NEW | 76.5 |
| 20 |  $PRAXPUT | Praxis Precision Medicines, Inc. | $33.5M | — | NEW | — |
| 21 |  $AVR | Anteris Technologies Global Corp. | $33.3M | 2.0% | -39% | — |
| 22 |  $ABEO | ABEONA THERAPEUTICS INC. | $31.7M | 1.9% | +2% | 23.7 |
| 23 |  $KRYSPUT | Krystal Biotech, Inc. | $31.6M | — | NEW | 79.2 |
| 24 | $PTON | PELOTON INTERACTIVE, INC. | $30.2M | 1.8% | -57% | 54.3 |
| 25 |  $ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $28.8M | 1.8% | -60% | 33.9 |
| 26 |  $XTNT | Xtant Medical Holdings, Inc. | $28.8M | 1.8% | +0% | 26.9 |
| 27 |  $JACK | JACK IN THE BOX INC | $27.3M | 1.7% | +12% | 44.2 |
| 28 |  $GOGO | Gogo Inc. | $27.0M | 1.6% | -2% | 51.3 |
| 29 |  $IMAX | IMAX CORP | $26.2M | 1.6% | +28% | 59.6 |
| 30 |  $ZVRA | ZEVRA THERAPEUTICS, INC. | $25.8M | 1.6% | -29% | 72.8 |
| 31 |  $REGNCALL | REGENERON PHARMACEUTICALS, INC. | $24.9M | — | +0% | 71 |
| 32 |  $TITN | Titan Machinery Inc. | $23.9M | 1.5% | -10% | 35 |
| 33 |  $RMR | RMR GROUP INC. | $23.6M | 1.4% | +0% | 40.1 |
| 34 |  $FOSL | Fossil Group, Inc. | $22.8M | 1.4% | +2% | 29.6 |
| 35 |  $FOXF | FOX FACTORY HOLDING CORP | $22.2M | 1.4% | -12% | 30.4 |
| 36 |  $MLYS | Mineralys Therapeutics, Inc. | $22.1M | 1.4% | -8% | — |
| 37 |  $RDNW | RideNow Group, Inc. | $21.8M | 1.3% | +0% | 32.6 |
| 38 |  $SNAPCALL | Snap Inc | $21.3M | — | NEW | 56.2 |
| 39 | $QURE | uniQure N.V. | $21.0M | 1.3% | +92% | — |
| 40 |  $AURA | Aura Biosciences, Inc. | $21.0M | 1.3% | +39% | — |
| 41 |  $AGMB | Agomab Therapeutics NV | $20.4M | 1.2% | +31% | — |
| 42 |  $FULC | Fulcrum Therapeutics, Inc. | $20.0M | 1.2% | +80% | 32.9 |
| 43 |  $BNTC | Benitec Biopharma Inc. | $19.9M | 1.2% | +3% | — |
| 44 |  $ADMA | ADMA BIOLOGICS, INC. | $19.8M | 1.2% | NEW | 69.7 |
| 45 |  $CWH | Camping World Holdings, Inc. | $19.5M | 1.2% | -22% | 41.4 |
| 46 |  $BCRX | BIOCRYST PHARMACEUTICALS INC | $19.0M | 1.2% | -4% | 53.2 |
| 47 |  $MDXG | MIMEDX GROUP, INC. | $18.4M | 1.1% | +40% | 43.9 |
| 48 |  $ABVX | Abivax S.A. | $17.8M | 1.1% | -3% | — |
| 49 |  $USNA | USANA HEALTH SCIENCES INC | $17.3M | 1.1% | +0% | 38.4 |
| 50 |  $GLUE | Monte Rosa Therapeutics, Inc. | $15.8M | 1.0% | +0% | 30.3 |
| 51 |  $TNGX | Tango Therapeutics, Inc. | $15.7M | 0.9% | -60% | 17.6 |
| 52 |  $GERN | GERON CORP | $15.6M | 0.9% | +9% | — |
| 53 |  $VOR | Vor Biopharma Inc. | $15.6M | 0.9% | NEW | — |
| 54 | $CWHCALL | Camping World Holdings, Inc. | $15.3M | — | +0% | 41.4 |
| 55 |  $KROS | Keros Therapeutics, Inc. | $15.1M | 0.9% | +4% | 27.3 |
| 56 |  $SLN | Silence Therapeutics plc | $14.8M | 0.9% | -37% | — |
| 57 |  $APYX | Apyx Medical Corp | $14.7M | 0.9% | -5% | 27.6 |
| 58 |  $JCAP | Jefferson Capital, Inc. / DE | $14.6M | 0.9% | +0% | 57.6 |
| 59 | $HLF | HERBALIFE LTD. | $14.6M | 0.9% | -18% | — |
| 60 |  $PLNT | Planet Fitness, Inc. | $14.6M | 0.9% | NEW | 67.6 |
| 61 |  $VSTM | Verastem, Inc. | $13.7M | 0.8% | +0% | 29.7 |
| 62 | $FOXFCALL | FOX FACTORY HOLDING CORP | $13.6M | — | +0% | 30.4 |
| 63 |  $DSGR | Distribution Solutions Group, Inc. | $13.5M | 0.8% | +0% | 52.5 |
| 64 |  $RYAM | RAYONIER ADVANCED MATERIALS INC. | $13.3M | 0.8% | +6% | 31.5 |
| 65 | — | HELIX ACQUISITION CORP III - USD CL A ORD SHS | $13.3M | 0.8% | +0% | — |
| 66 |  $ADCT | ADC Therapeutics SA | $13.2M | 0.8% | +120% | 21.8 |
| 67 |  $PCVX | Vaxcyte, Inc. | $12.9M | 0.8% | -7% | — |
| 68 |  $IRD | Opus Genetics, Inc. | $12.6M | 0.8% | +82% | — |
| 69 |  $JANX | Janux Therapeutics, Inc. | $12.4M | 0.8% | +0% | 30.1 |
| 70 |  $CHYMCALL | Chime Financial, Inc. | $12.3M | — | +0% | 53.5 |
| 71 |  $AMAN | Amanat Acquisition Corp. | $12.2M | 0.7% | NEW | — |
| 72 |  $INSP | Inspire Medical Systems, Inc. | $12.0M | 0.7% | NEW | 63.7 |
| 73 |  $FLWS | 1 800 FLOWERS COM INC | $11.7M | 0.7% | +0% | 26.8 |
| 74 |  $XFOR | X4 Pharmaceuticals, Inc | $11.4M | 0.7% | +0% | 28 |
| 75 | $RDNWCALL | RideNow Group, Inc. | $11.3M | — | +0% | 32.6 |
| 76 |  $ITGR | Integer Holdings Corp | $10.4M | 0.6% | -35% | 55.9 |
| 77 |  $IVA | Inventiva S.A. | $10.2M | 0.6% | NEW | — |
| 78 |  $ILPT | Industrial Logistics Properties Trust | $9.9M | 0.6% | -34% | 38.1 |
| 79 |  $DUOL | Duolingo, Inc. | $9.6M | 0.6% | -16% | 74.5 |
| 80 |  $RSVR | Reservoir Media, Inc. | $9.3M | 0.6% | +0% | 54.9 |
| 81 |  $GUTS | FRACTYL HEALTH, INC. | $9.0M | 0.6% | -16% | 10 |
| 82 |  $DHX | DHI GROUP, INC. | $8.8M | 0.5% | +0% | 42.9 |
| 83 |  $AMLX | Amylyx Pharmaceuticals, Inc. | $8.7M | 0.5% | -9% | 8.7 |
| 84 |  $KRRO | Korro Bio, Inc. | $8.7M | 0.5% | +0% | 14.1 |
| 85 |  $ALEC | Alector, Inc. | $8.7M | 0.5% | +53% | 10.9 |
| 86 |  $NDLS | NOODLES & Co | $8.3M | 0.5% | +0% | 32.4 |
| 87 |  $RHCALL | RH | $8.2M | — | +0% | 55.2 |
| 88 |  $CDXS | CODEXIS, INC. | $8.2M | 0.5% | -12% | 28.9 |
| 89 |  $CATX | Perspective Therapeutics, Inc. | $7.9M | 0.5% | NEW | — |
| 90 | $TBBKCALL | Bancorp, Inc. | $7.9M | — | +0% | 61.1 |
| 91 |  $IACQ | Irenic Acquisition Corp. | $7.6M | 0.5% | NEW | — |
| 92 | $QUREPUT | uniQure N.V. | $7.4M | — | NEW | — |
| 93 |  $DMRA | Damora Therapeutics, Inc. | $7.2M | 0.4% | +0% | — |
| 94 |  $VMD | VIEMED HEALTHCARE, INC. | $7.2M | 0.4% | -28% | 61.5 |
| 95 |  $UNCY | Unicycive Therapeutics, Inc. | $6.6M | 0.4% | +49% | — |
| 96 |  $COOK | Traeger, Inc. | $6.5M | 0.4% | -19% | 30.5 |
| 97 |  $FORR | FORRESTER RESEARCH, INC. | $6.4M | 0.4% | +10% | 24.7 |
| 98 | $ABEOCALL | ABEONA THERAPEUTICS INC. | $6.3M | — | +0% | 23.7 |
| 99 |  $LXEO | Lexeo Therapeutics, Inc. | $6.1M | 0.4% | +8% | — |
| 100 | $RH | RH | $6.0M | 0.4% | -37% | 55.2 |
| 101 |  $COCH | Envoy Medical, Inc. | $6.0M | 0.4% | +0% | — |
| 102 |  $ELOX | Eloxx Pharmaceuticals, Inc. | $5.6M | 0.3% | NEW | — |
| 103 |  $IKT | Inhibikase Therapeutics, Inc. | $5.5M | 0.3% | +0% | — |
| 104 |  $TRAX | First Tracks Biotherapeutics, Inc. | $5.0M | 0.3% | NEW | — |
| 105 |  $MARA | MARA Holdings, Inc. | $5.0M | 0.3% | +0% | 36.5 |
| 106 |  $HAIN | HAIN CELESTIAL GROUP INC | $4.8M | 0.3% | +0% | 25 |
| 107 |  $ALTG | ALTA EQUIPMENT GROUP INC. | $4.7M | 0.3% | -22% | 36.3 |
| 108 |  $KIDS | ORTHOPEDIATRICS CORP | $4.6M | 0.3% | +22% | 37.8 |
| 109 |  $ALT | Altimmune, Inc. | $4.6M | 0.3% | NEW | 8 |
| 110 |  $TLSI | TriSalus Life Sciences, Inc. | $4.5M | 0.3% | -52% | 29.7 |
| 111 |  $TELA | TELA Bio, Inc. | $4.4M | 0.3% | +15% | 25.2 |
| 112 |  $STKS | ONE Group Hospitality, Inc. | $4.3M | 0.3% | +0% | 41.8 |
| 113 |  $DRIO | DarioHealth Corp. | $4.0M | 0.3% | +0% | 18.8 |
| 114 |  $IMUX | IMMUNIC, INC. | $3.9M | 0.2% | -90% | — |
| 115 |  $ZLAB | Zai Lab Ltd | $3.8M | 0.2% | NEW | — |
| 116 |  $TLPH | TALPHERA, INC. | $3.6M | 0.2% | +0% | — |
| 117 | $CHYM | Chime Financial, Inc. | $3.5M | 0.2% | -14% | 53.5 |
| 118 |  $VENU | Venu Holding Corp | $3.5M | 0.2% | -24% | 23 |
| 119 |  $PAYO | Payoneer Global Inc. | $3.4M | 0.2% | +0% | 53.5 |
| 120 |  $ELUT | ELUTIA INC. | $3.1M | 0.2% | +0% | — |
| 121 |  $KLRA | Kailera Therapeutics, Inc. | $3.1M | 0.2% | NEW | — |
| 122 |  $RLYB | Rallybio Corp | $3.0M | 0.2% | -37% | — |
| 123 |  $ARTV | Artiva Biotherapeutics, Inc. | $2.9M | 0.2% | NEW | 9.7 |
| 124 |  $DXLG | DESTINATION XL GROUP, INC. | $2.8M | 0.2% | +0% | 23.2 |
| 125 |  $EDIT | Editas Medicine, Inc. | $2.8M | 0.2% | NEW | 33.4 |
| 126 |  $EHTH | eHealth, Inc. | $2.6M | 0.2% | +0% | 52.8 |
| 127 |  $JATT | JATT II Acquisition Corp. | $2.6M | 0.2% | NEW | — |
| 128 |  $ARVN | ARVINAS, INC. | $2.5M | 0.1% | +0% | 36.6 |
| 129 |  $RDI | READING INTERNATIONAL INC | $2.5M | 0.1% | +0% | 28 |
| 130 |  $NSPR | InspireMD, Inc. | $2.4M | 0.1% | +0% | — |
| 131 |  $AYTU | AYTU BIOPHARMA, INC | $2.3M | 0.1% | +0% | 23.4 |
| 132 |  $AKBA | Akebia Therapeutics, Inc. | $2.3M | 0.1% | +0% | 45.3 |
| 133 |  $SRL | Scully Royalty Ltd. | $2.3M | 0.1% | +0% | — |
| 134 |  $TRDA | Entrada Therapeutics, Inc. | $2.2M | 0.1% | +89% | 7.3 |
| 135 | $PCVXCALL | Vaxcyte, Inc. | $2.0M | — | +0% | — |
| 136 |  $GAIA | GAIA, INC | $1.9M | 0.1% | +0% | 25.4 |
| 137 |  $CRMT | AMERICAS CARMART INC | $1.8M | 0.1% | +0% | 29.7 |
| 138 |  $ALXO | ALX ONCOLOGY HOLDINGS INC | $1.6M | 0.1% | NEW | — |
| 139 |  $POCI | PRECISION OPTICS CORPORATION, INC. | $1.4M | 0.1% | +0% | — |
| 140 |  $BRCC | BRC Inc. | $1.4M | 0.1% | -52% | 41.3 |
| 141 |  $YARW | Yarrow Bioscience, Inc. | $1.3M | 0.1% | +0% | — |
| 142 |  $ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | $990,925 | 0.1% | +0% | — |
| 143 |  $ACU | ACME UNITED CORP | $974,776 | 0.1% | +0% | 44.4 |
| 144 |  $PERF | Perfect Corp. | $969,316 | 0.1% | +0% | — |
| 145 | $SNAP | Snap Inc | $888,000 | 0.1% | NEW | 56.2 |
| 146 | $ASPS | ALTISOURCE PORTFOLIO SOLUTIONS S.A. | $693,647 | 0.0% | +0% | — |
| 147 |  $CLRB | Cellectar Biosciences, Inc. | $611,594 | 0.0% | NEW | — |
| 148 |  $SGRP | SPAR Group, Inc. | $545,926 | 0.0% | +0% | 16 |
| 149 |  $AZTR | Azitra, Inc. | $371,444 | 0.0% | NEW | — |
| 150 |  $PHGE | BiomX Inc. | $215,232 | 0.0% | +453% | 29.4 |
| 151 |  $APRE | Aprea Therapeutics, Inc. | $165,081 | 0.0% | +0% | — |
| 152 |  $GFAI | Guardforce AI Co., Ltd. | $5,420 | 0.0% | +0% | — |
New Positions (26)
$NBIXCALL NEUROCRINE BIOSCIENCES INC$33.7M$PRAXPUT Praxis Precision Medicines, Inc.$33.5M$KRYSPUT Krystal Biotech, Inc.$31.6M$SNAPCALL Snap Inc$21.3M$ADMA ADMA BIOLOGICS, INC.$19.8M$VOR Vor Biopharma Inc.$15.6M$PLNT Planet Fitness, Inc.$14.6M$AMAN Amanat Acquisition Corp.$12.2M$INSP Inspire Medical Systems, Inc.$12.0M$IVA Inventiva S.A.$10.2M$CATX Perspective Therapeutics, Inc.$7.9M$IACQ Irenic Acquisition Corp.$7.6M$QUREPUT uniQure N.V.$7.4M$ELOX Eloxx Pharmaceuticals, Inc.$5.6MExited Positions (25)
$SLNO SOLENO THERAPEUTICS INC
$TEVACALL TEVA PHARMACEUTICAL INDUSTRIES LTD$SLNOCALL SOLENO THERAPEUTICS INC
$ALGNCALL ALIGN TECHNOLOGY INC
$ASRT Assertio Holdings, Inc.
$CNTA Centessa Pharmaceuticals plc
$COGT Cogent Biosciences, Inc.
$SVC Service Properties Trust
$SLDB Solid Biosciences Inc.
$DNTH Dianthus Therapeutics, Inc. /DE/
$KOS Kosmos Energy Ltd.
$RVMD Revolution Medicines, Inc.
$CZR Caesars Entertainment, Inc.
$UPB Upstream Bio, Inc.
$NNBR NN INCBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Nantahala Capital Management, LLC including:
Track Nantahala Capital Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Nantahala Capital Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Nantahala Capital Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Nantahala Capital Management, LLC (SEC CIK: 1472322), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Nantahala Capital Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.